Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: All Mtn Ski who wrote (796)	12/29/1999 8:29:00 AM
From: William Partmann	Read Replies (1) \| Respond to of 10345

Elan files application to U.S. FDA for pain drug NEW YORK, Dec 29 (Reuters) - Irish pharmaceuticals company Elan Corp. Plc (NYSE:ELN - news) (quote from Yahoo! UK & Ireland: ELA.L) on Wednesday said it had submitted a new drug application to the U.S. Food and Drug Administration for ziconotide, a potential treatment for intractable pain. The company said in a statement that the drug has shown a significant reduction in pain compared to a placebo in two clinical studies of more than 1,000 patients. Patients included in the pain studies had either failed systemic opioid (morphine like) therapy, or had become intolerant of therapy due to side effects. The intractable pain was caused by a wide array of underlying conditions.